240 participants
Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-07-28
- Start Date:
- 2020-05-10
- Completion:
- 2022-06-30
Conditions
- IBS - Irritable Bowel Syndrome
- Gut Microbiota
Interventions
- DRUG
No Results Yet